Resilience for Adolescents and Young People Study (RAYS). An interventional study for offspring of women with breast cancer

Not Applicable

• Conditions: Distress; Anxiety; Mental Health - Anxiety

• Registration Number: ACTRN12622000485730
• Lead Sponsor: Breast Cancer Research Centre - WA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-28
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

•Written informed consent of participants (parental/legal guardian consent required in subjects under 18 years)
•Written informed consent of the parent Consent for Use of Personal Health Information”
•Parent must be a current patient of Perth Breast Cancer Institute (clinical arm of BCRC-WA) clinician(s).
•Parent includes biological or non-biological (i.e., Adoptive or Foster)
•Parent diagnosed with stage I to IV breast cancer (including those who remain disease-free from breast cancer, have experienced a local recurrence or have metastatic breast cancer) within the last 5 years
•Parent has life expectancy greater than 6 months.
•Male and female offspring aged between 14-24yrs at the time of consent
•Living with the parent (applicable to offspring 14-17 years of age)
•Both parent and offspring able to read English and understand questions asked
•Both parent and offspring who resides in Western Australia
•Offspring whose parent with breast cancer is the sole parent may be included.
•Offspring with personal cancer if treatment has finished and in remission are eligible
•Evidence of no disease progression in patients with metastatic breast cancer within 3 months prior to study consent (i.e the mother is assessed as having stable metastatic disease)

Exclusion Criteria

•No social contact with mother who has breast cancer.
•Diagnosis of severe mental health problems, including recent suicidal and self-harm behaviours within the last 3 months.
•Father or sibling currently being treated for cancer.

Study & Design

• Study Type: Interventional
• Study Design: Not specified